• Patient Login
Calidi Biotherapeutics
  • Our Company
    • Our Company
    • Our Team
    • Scientific & Medical Advisory Board
  • Our Science
    • Our Science
    • Our Technologies
    • Our Pipeline
  • Our Responsibility
  • Press
  • Contact
    • Contact
    • Investors

Press Releases & News

Press Release

Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

SAN DIEGO, Nov. 6, 2018  -- Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of cell-delivered oncolytic viruses for the treatment of cancer, today announced that data from its clinical studies in late-stage cancer patients will be presented at the Society for Immunotherapy of Cancer…
Calidi Biotherapeutics
Calidi BiotherapeuticsNovember 6, 2018

Recent Posts

  • Calidi Biotherapeutics Launches Scientific and Medical Advisory Board
  • Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
  • Calidi Biotherapeutics, Inc. Granted New Patent from USPTO for Cell-Based Delivery Of Oncolytic Vaccinia Viruses
  • Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO

Archives

  • January 2019
  • November 2018
  • October 2018
  • May 2018

Categories

  • Press Release

Meta

  • Register
  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

© 2019 Calidi Biotherapeutics.

  • Our Company
    • Our Company
    • Our Team
    • Scientific & Medical Advisory Board
  • Our Science
    • Our Science
    • Our Technologies
    • Our Pipeline
  • Our Responsibility
  • Press
  • Contact
    • Contact
    • Investors
  • Patient Login